Washington University School of Medicine in St. Louis | Washington University Therapeutics (WT) CRS
Research site
Site insights
Top conditions
Top treatments
TDF
Maraviroc
Raltegravir
FTC
Cabotegravir
Pramipexole
d4T
Nucleoside
NVP
Tenofovir Disoproxil Fumarate
Parent organization
This site is a part of Washington University School of Medicine in St. Louis
Curious how this site stacks up to its peers?
Data sourced from clinicaltrials.gov
Contact this site
Contact ID CRU about Studies
Verified by this site
Active trials
2 of 38 total trials
The purpose of this study is to evaluate the safety, tolerability, and efficacy of N-803, an IL-15 superagonist, with or without combination broadly...
Active, not recruiting
HIV Infection
Biological: 10-1074
Biological: N-803 (IL-15 Superagonist)
The purpose of this study was to compare the efficacy, safety, and durability of two different strategies to treat participants with a history of sub...
Active, not recruiting
HIV Infections
Drug: CAB-LA Loading Dose
Drug: RPV-LA Maintenance Dose
Trial sponsors
A
Clinical trials
Research sites
Resources
Legal
© Copyright 2026 Veeva Systems